Does tamoxifen prophylaxis for breast cancer provide long-term prevention?

被引：0

作者：

Bernardo Bonanni

Matteo Lazzeroni

Umberto Veronesi

机构：

[1] M Lazzeroni is a Fellow,B Bonanni is Co

[2] and U Veronesi is Scientific Director,Director of the Division of Cancer Prevention and Genetics

[3] at the European Institute of Oncology,undefined

[4] Milan,undefined

[5] Italy.,undefined

来源：

Nature Clinical Practice Oncology | 2007年 / 4卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：568 / 569

页数：1

共 5 条

[1]

Cuzick J(2002)First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial Lancet 360 817-824

[2]

Rebbeck T(2002)Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations N Engl J Med 346 1616-1622

[3]

Powles TJ(2007)Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial J Natl Cancer Inst 99 283-290

[4]

Veronesi U(2007)Tamoxifen for the prevention of breast cancer: late results of the Italian Randomized Tamoxifen Prevention Trial among women with hysterectomy J Natl Cancer Inst 99 727-737

[5]

Fisher B(2005)Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study J Natl Cancer Inst 97 1652-1662

← 1 →